Hyrozide 12.5 Tablet contains Hydrochlorothiazide 12.5 mg, a thiazide diuretic used to manage high blood pressure and fluid retention (edema) associated with congestive heart failure, kidney disorders, or liver disease.
Hydrochlorothiazide helps by removing excess water and sodium from the body, reducing blood pressure and swelling. It is commonly prescribed as monotherapy or in combination with other antihypertensive agents.
This tablet belongs to the cardiology and nephrology segment and is regularly prescribed in cardiology OPDs, clinics, and hospital setups. It is recognized as an essential hypertension control medicine and maintains strong recurring demand in pharmacies.
For PCD franchise distributors, institutional buyers, and third-party manufacturers, Hyrozide 12.5 is a value-driven portfolio addition with strong market acceptance and continuous prescription support across India.
Some individuals may experience increased urination, dizziness, headache, electrolyte imbalance (such as low potassium or sodium), dry mouth, or weakness. Rare but serious reactions may include dehydration, gout flare-ups, or kidney function changes. Seek medical advice if symptoms persist or worsen.
Hyrozide 12.5 Tablet is commonly used in the management of hypertension (high blood pressure) and is also prescribed to treat edema associated with conditions like congestive heart failure, liver cirrhosis, and kidney disorders. It helps in maintaining long-term blood pressure control and supporting cardiovascular health.
Hyrozide 12.5 Tablet should be taken exactly as directed by a healthcare professional. Regular monitoring of electrolytes, kidney function, and blood pressure is advised during treatment. Inform your doctor if you have diabetes, gout, kidney disease, or are taking other antihypertensive medicines.
Store Hyrozide 12.5 Tablet in a cool, dry place below 25°C, away from direct light and moisture. Keep out of reach of children.